|
Adcirca (tadalafil)
20 mg tablets
|
60 tablets
per 30 days
|
40 mg per day
|
|
Alyq (tadalafil)
20 mg tablets
|
60 tablets
per 30 days
|
|
Adempas (riociguat)
0.5 mg tablets
|
90 tablets
per 30 days
|
The recommended starting dosage is 1
mg taken 3 times a day. For patients
who cannot tolerate the hypotensive
effect of Adempas, consider a starting
dose of 0.5 mg taken three times a
day. If systolic blood pressure
remains greater than 95 mmHg and
the patient has no signs or symptoms
of hypotension, up-titrate by 0.5 mg
taken three times a day. Dose
increases should be no sooner than 2
weeks apart. The dose can be
increased to the highest tolerated
dosage, up to a maximum of 2.5 mg
taken 3 times per day. If at any time,
the patient has symptoms of
hypotension, decrease the dosage by
0.5 mg taken three times per day.
|
|
Adempas (riociguat)
1 mg tablets
|
90 tablets
per 30 days
|
|
Adempas (riociguat)
1.5 mg tablets
|
90 tablets
per 30 days
|
|
Adempas (riociguat)
2 mg tablets
|
90 tablets
per 30 days
|
|
Adempas (riociguat)
2.5 mg tablets
|
90 tablets
per 30 days
|
|
Letairis
(ambrisentan)
5 mg tablets
|
30 tablets
per 30 days
|
Initiate treatment at 5 mg once daily
with or without tadalafil 20 mg once
daily. At 4-week intervals, either the
dose of Letairis or tadalafil can be
increased, as needed and tolerated,
to Letairis 10 mg or tadalafil 40 mg.
|
|
Letairis
(ambrisentan)
10 mg tablets
|
30 tablets
per 30 days
|
|
Liqrev (sildenafil)
10 mg/mL
oral suspension
|
732 mL
per 30 days
|
20 mg three times a day; may titrate
to a maximum dose of 80 mg three
times a day
|
|
Opsumit (macitentan)
10 mg tablets
|
30 tablets
per 30 days
|
10 mg per day
|
|
Revatio (sildenafil)
10 mg/mL
oral suspension
|
784 mL
per 30 days
|
Patients ≥ 18 years of age:
20 mg three times a day; may titrate
to a maximum dose of 80 mg three
times a day
Patients 1 to 17 years of age:
• ≤20 kg: 10 mg three times a day
• >20 kg to <45 kg: 20 mg three
times a day
• ≥45 kg: 20 mg three times a day;
may be titrated to a maximum
dose of 40 mg three times a day
|
|
Revatio (sildenafil)
20 mg tablets
|
360 tablets
per 30 days
|
|
Tadliq (tadalafil)
20 mg/5 mL
oral suspension
|
300 mL
per 30 days
|
40 mg (10 mL) per day
|
|
Tracleer (bosentan)
125 mg tablets
|
60 tablets
per 30 days
|
Patients >12 years of age and >40
kg: Initiate treatment at 62.5 mg
twice daily for 4 weeks and then
increase to maintenance dose of 125
mg twice daily.
Patients >12 years of age and <40
kg: Initial and maintenance dosing:
62.5 mg twice daily
Patients <12 years of age: Initial and
maintenance dosing:
• >4-8 kg: 16 mg twice daily
• >8-16 kg: 32 mg twice daily
• >16-24 kg: 48 mg twice daily
• >24-40 kg: 64 mg twice daily
|
|
Tracleer (bosentan)
62.5 mg tablets
|
60 tablets
per 30 days
|
|
Tracleer (bosentan)
32 mg tablets
|
112 tablets
per 28 days
|
|
Tyvaso (treprostinil)
0.6 mg/mL inhalation
solution
|
81.2 mL
(28 ampules)
per 28 days
|
Up to 72 mcg four times a day
|
|
Tyvaso (treprostinil)
DPI 16 mcg and 32
mcg Inhalation
Powder Titration Kit
|
196 cartridges
per 28 days
|
Initial dosage: One 16 mcg cartridge
per treatment session, four times
daily.
Dosage should be increased by an
additional 16 mcg per treatment
session at approximately 1- to 2-
week intervals, if tolerated
Titrate to target maintenance doses of
48 mcg to 64 mcg per treatment
sessions, four times daily
If the prescribed dose is higher than
64 mcg per treatment session, more
than 1 cartridge will be needed per
session.
|
|
Tyvaso (treprostinil)
DPI 16 mcg, 32 mcg,
and 48 mcg
Inhalation Powder
Titration Kit
|
252 cartridges
per 28 days
|
|
Tyvaso (treprostinil)
DPI 16 mcg
Inhalation Powder
Maintenance Kit
|
112 cartridges
per 28 days
|
|
Tyvaso (treprostinil)
DPI 32 mcg
Inhalation Powder
Maintenance Kit
|
112 cartridges
per 28 days
|
|
Tyvaso (treprostinil)
DPI 48 mcg
Inhalation Powder
Maintenance Kit
|
112 cartridges
per 28 days
|
|
Tyvaso (treprostinil)
DPI 64 mcg
Inhalation Powder
Maintenance Kit
|
112 cartridges
per 28 days
|
|
Tyavso (treprostinil)
DPI 32 mcg and 48
mcg Inhalation
Powder Maintenance
Kit
|
224 cartridges
per 28 days
|
|
Uptravi (selexipag)
200 mcg tablets
|
140 tablets
per 28 days
|
Starting dose: 200 mcg twice daily.
Increase the dose by 200 mcg twice
daily at weekly intervals to the highest
tolerated dose up to 1600 mcg twice
daily.
|
|
Uptravi (selexipag)
400 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
600 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
800 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
1000 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
1200 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
1400 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
1600 mcg tablets
|
60 tablets
per 30 days
|
|
Uptravi (selexipag)
titration pack (200
mcg/800 mcg
tablets)
|
1 pack (140-200mcg
tablets, 60- 800 mcg
tablets) per 28 days
|
|
Ventavis (iloprost)
10 mcg/mL inhalation
solution
|
270 ampules
per 30 days
|
5 mcg up to nine times per day. The 20
mcg/mL concentration is intended for
patients who are maintained at the 5
mcg dose and who have repeatedly
experienced extended treatment times
which could result in incomplete
dosing.
|
|
Ventavis (iloprost)
20 mcg/mL
inhalation solution
|
270 ampules
per 30 days
|
